Peer-reviewedCC BY-NC-SAActa gastroenterologica Latinoamericana
Glucagon-Like Peptide-1 Receptor Agonist and Gastrointestinal Adverse Effects: A Comprehensive Review Efectos adversos gastrointestinales del agonista del receptor de GLP-1: revisión narrativa
- 1Division of Gastroenterology and Hepatology, Mayo Clinic. Rochester, Minnesota, USA Division of Gastroenterology and Hepatology, Mayo Clinic
Related
- Comparative Short-Term Risk of Severe Gastrointestinal Events Associated with Opioid Type Among Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists
- De-escalating Therapy in Obstructive Sleep Apnoea After Glucagon-Like Peptide-1 Receptor Agonist-Induced Weight Loss: A Narrative Review
- Glucagon-like peptide-1 receptor agonists beyond weight loss: A paradigm shift in cardiovascular prevention
- Divergent ocular safety profiles of glucagon-like peptide-1 receptor agonists: a pharmacological heterogeneity framework
- Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
BibTeX
@article{cisneros2026glucagonlike,
title = {{Glucagon-Like Peptide-1 Receptor Agonist and Gastrointestinal Adverse Effects: A Comprehensive Review Efectos adversos gastrointestinales del agonista del receptor de GLP-1: revisión narrativa}},
author = {Julio Zúñiga Cisneros and Michael Camilleri and Madhusudan Grover},
journal = {Acta gastroenterologica Latinoamericana},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13660854},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - Glucagon-Like Peptide-1 Receptor Agonist and Gastrointestinal Adverse Effects: A Comprehensive Review Efectos adversos gastrointestinales del agonista del receptor de GLP-1: revisión narrativa
AU - Julio Zúñiga Cisneros
AU - Michael Camilleri
AU - Madhusudan Grover
PY - 2026
DA - 2026/10/16
JO - Acta gastroenterologica Latinoamericana
UR - https://europepmc.org/article/PMC/PMC13660854
SN - 0300-9033
SN - 2469-1119
ER -